Inhibition of p38 kinase activity using aryland heteroaryl substituted heterocyclic ureas
semanticscholar（2017）
摘要
This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in Such therapy.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要